← Leaderboards
Matthew David Marsden
University Of California Los Angeles
$4,091,524
Attributed
$6,019,122
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,019,122 · 4
By mechanism
R01$3,855,196 · 1
P01$1,740,426 · 2
R21$423,500 · 1
Top collaborators
- Anjie Zhen4 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Paul Wender$20,449,594
- Scott G Kitchen$17,099,191
- Jerome A. Zack$38,514,975
- Anjie Zhen$4,232,021
- Irvin S.y. Chen$31,294,828
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionIn VivoMouse ModelCellsHumanized MouseAntiretroviral TherapyViral ReboundT-Cell ActivationInsightImmune ActivationEngineeringAffectViral Load ResultImmunityPlasmaPreventNovel StrategiesMonitorPathogenesisVariantAnimal ModelIn VitroDeep SequencingDisease Progression
Grant awards (11)
Induction of autophagy to enhance CAR-T cells in HIV cure approaches$1,515,431
R01 · FY2025 · AI
Induction of autophagy to enhance CAR-T cells in HIV cure approaches$768,446
R01 · FY2024 · AI
Induction of autophagy to enhance CAR-T cells in HIV cure approaches$775,321
R01 · FY2023 · AI
Induction of autophagy to enhance CAR-T cells in HIV cure approaches$795,998
R01 · FY2022 · AI
Defining the causes and consequences of viral rebound$336,816
P01 · FY2021 · AI · contact PI
Defining the causes and consequences of viral rebound$352,360
P01 · FY2020 · AI · contact PI
Defining the causes and consequences of viral rebound$346,250
P01 · FY2019 · AI · contact PI
Defining the causes and consequences of viral rebound$350,802
P01 · FY2018 · AI · contact PI
Defining the causes and consequences of viral rebound$354,198
P01 · FY2017 · AI · contact PI
Novel method for evaluating HIV latency and persistence in vivo$231,000
R21 · FY2017 · AI · contact PI
Novel method for evaluating HIV latency and persistence in vivo$192,500
R21 · FY2016 · AI · contact PI